{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:14Z","timestamp":1759451954498,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2018.01.022","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:59:13Z","timestamp":1516323553000},"page":"1027-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa"],"prefix":"10.1016","volume":"36","author":[{"given":"Oumar","family":"Guindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seydou","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Ekra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoul H.","family":"Beavogui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Cases of Wild Poliovirus by Country and Year. Available at: <http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx> [accessed 30\/03\/2017].","key":"10.1016\/j.vaccine.2018.01.022_b0005"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.01.022_b0010","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1093\/infdis\/jit454","article-title":"Outbreaks of paralytic poliomyelitis during 1996\u20132012: the changing epidemiology of a disease in the final stages of eradication","volume":"210","author":"Mach","year":"2014","journal-title":"J Infect Dis"},{"unstructured":"Progress toward interruption of wild poliovirus transmission--worldwide, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:308\u201312.","key":"10.1016\/j.vaccine.2018.01.022_b0015"},{"unstructured":"Progress toward interruption of wild poliovirus transmission \u2013 worldwide, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:545\u201350.","key":"10.1016\/j.vaccine.2018.01.022_b0020"},{"key":"10.1016\/j.vaccine.2018.01.022_b0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.15585\/mmwr.mm6505a5","article-title":"Notes from the field: circulating vaccine-derived poliovirus outbreaks - five countries, 2014\u20132015","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"unstructured":"POLIO ERADICATION AND ENDGAME STRATEGIC PLAN 2013\u20132018. Available at: <http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/EndGameStratPlan_WHAversion.pdf>.","key":"10.1016\/j.vaccine.2018.01.022_b0030"},{"unstructured":"IVB\/WHO. Data, statistics and graphics. Available at: <http:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/> [accessed 10\/07\/2017].","key":"10.1016\/j.vaccine.2018.01.022_b0035"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.01.022_b0040","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/infdis\/jit492","article-title":"Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India","volume":"210","author":"Bahl","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.01.022_b0045","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1093\/infdis\/jiu379","article-title":"An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India","volume":"210","author":"Bahl","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.01.022_b0050","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/infdis\/jiu204","article-title":"Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad Western Uttar Pradesh","volume":"210","author":"Deshpande","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.022_b0055","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jegh.2015.06.004","article-title":"Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014","volume":"5","author":"Gamage","year":"2015","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.vaccine.2018.01.022_b0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jmv.23228","article-title":"A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri Nigeria","volume":"84","author":"Baba","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.01.022_b0065","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2012.09.023","article-title":"Seroprevalence of poliovirus antibodies amongst children in Zaria Northern Nigeria","volume":"30","author":"Giwa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.022_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4314\/ahs.v14i1.19","article-title":"Seroprevalence of cytomegalovirus among pregnant women attending Murtala Mohammed Specialist Hospital Kano Nigeria","volume":"14","author":"Hamid","year":"2014","journal-title":"Afr Health Sci"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.01.022_b0075","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/infdis\/jiv774","article-title":"Role of serial polio seroprevalence studies in guiding implementation of the polio eradication initiative in Kano, Nigeria: 2011\u20132014","volume":"213","author":"Craig","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.01.022_b0080","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1016\/j.vaccine.2016.08.058","article-title":"Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State Nigeria","volume":"34","author":"Iliyasu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.022_b0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.01.022_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","author":"Anand","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.01.022_b0095","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.vaccine.2015.04.055","article-title":"Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan","volume":"33","author":"Saleem","year":"2015","journal-title":"Vaccine"},{"unstructured":"WHO. Poliovirus Outbreak Response Guidelines. Available at: <http:\/\/polioeradication.org\/tools-and-library\/resources-for-polio-eradicators\/gpei-tools-protocols-and-guidelines\/> [accessed 05\/05\/2017].","key":"10.1016\/j.vaccine.2018.01.022_b0100"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18300562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:21Z","timestamp":1759400661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18300562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X18300562"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}